Movalis®

Meloxicam indications :

• The removal of pain during sports trauma
• Osteoarthritis (arthrosis, degenerative joint diseases)
• Rheumatoid arthritis
• Ankylosing spondylitis
• Degenerative and inflammatory diseases of the joints, accompanied by severe pain syndrome

Movalis® is administered by deep intramuscular injection because meloxicam should not be administered intravenously.
Intramuscular administration of Movalis® is indicated only during the first few days of therapy. In the future, treatment is continued with tablets.
The recommended dose of Meloxicam is 7.5 mg or 15 mg 1 time per day, depending on the intensity of pain and the severity of the inflammatory process.